{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T21:21:02Z","timestamp":1785532862915,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","advancesradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.adro.2024.101648","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T01:07:54Z","timestamp":1727485674000},"page":"101648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ultra\u2013Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-842X","authenticated-orcid":false,"given":"Susan Y.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny Q.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Fetooh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gohar S.","family":"Manzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey L.","family":"Corrigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Schrank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Chihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis E. Malpica","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael E.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sattva S.","family":"Neelapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Strati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta J.","family":"Nastoupil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouthaina S.","family":"Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea C.","family":"Pinnix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5727-7594","authenticated-orcid":false,"given":"Jillian R.","family":"Gunther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2024.101648_bib0001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12308-017-0302-2","article-title":"Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma","volume":"10","author":"Schreuder","year":"2017","journal-title":"J Hematop"},{"key":"10.1016\/j.adro.2024.101648_bib0002","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/bjh.15444","article-title":"Stage I non-Hodgkin lymphoma: Difference in survival outcome by primary extranodal site of involvement","volume":"185","author":"Chihara","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.adro.2024.101648_bib0003","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.02.00404102","article-title":"Primary pulmonary lymphoma","volume":"20","author":"Cadranel","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.adro.2024.101648_bib0004","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1470-2045(20)30686-0","article-title":"4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial","volume":"22","author":"Hoskin","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2024.101648_bib0005","unstructured":"National Comprehensive Cancer Network. B-cell lymphomas (version 6.2023). Accessed August 28, 2023. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf."},{"key":"10.1016\/j.adro.2024.101648_bib0006","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1182\/bloodadvances.2021004939","article-title":"Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?","volume":"5","author":"Imber","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.adro.2024.101648_bib0007","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1470-2045(14)70036-1","article-title":"4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2024.101648_bib0008","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/10428194.2015.1040012","article-title":"Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy","volume":"57","author":"Akhtari","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.adro.2024.101648_bib0009","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamaoncol.2024.2112","article-title":"Response-adapted ultralow-dose radiation therapy for orbital indolent B-cell lymphoma a phase 2 nonrandomized controlled trial supplemental content","volume":"10","author":"Pinnix","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2024.101648_bib0010","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/S2352-3026(24)00133-9","article-title":"Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial","volume":"11","author":"Gunther","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.adro.2024.101648_bib0011","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2024.101648_bib0012","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijrobp.2015.01.040","article-title":"Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent","volume":"92","author":"Teckie","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101648_bib0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2024.101648_bib0014","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210012","article-title":"Efficacy of low-dose radiotherapy (2 Gy \u00d7 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas","volume":"94","author":"Cerrato","year":"2021","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2024.101648_bib0015","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ijrobp.2013.04.035","article-title":"Low-dose radiation therapy (2 Gy \u00d7 2) in the treatment of orbital lymphoma","volume":"86","author":"Fasola","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101648_bib0016","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1016\/j.ijrobp.2012.01.005","article-title":"Low-dose radiation treatment in pulmonary mucosa-associated lymphoid tissue lymphoma: a plausible approach? A single-institution experience in 10 patients","volume":"83","author":"Girinsky","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101648_bib0017","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1080\/10428194.2023.2255706","article-title":"Very low-dose radiotherapy for extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue","volume":"64","author":"Freret","year":"2023","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.adro.2024.101648_bib0018","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1182\/bloodadvances.2020003213","article-title":"Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue","volume":"5","author":"Joffe","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.adro.2024.101648_bib0019","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3121\/cmr.2017.1341","article-title":"Pulmonary MALT lymphoma in patients with Sj\u00f6gren's syndrome","volume":"15","author":"Yachoui","year":"2017","journal-title":"Clin Med Res"},{"key":"10.1016\/j.adro.2024.101648_bib0020","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/10428194.2019.1644333","article-title":"Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function","volume":"61","author":"Gunther","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"3 suppl","key":"10.1016\/j.adro.2024.101648_bib0021","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.ijrobp.2009.06.091","article-title":"Radiation dose-volume effects in the lung","volume":"76","author":"Marks","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101648_bib0022","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijrobp.2015.02.010","article-title":"Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma","volume":"92","author":"Pinnix","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109424002112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109424002112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T09:34:59Z","timestamp":1734341699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109424002112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2452109424002112"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2024.101648","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultra\u2013Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2024.101648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101648"}}